Compare FDC LTD. with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs STRIDES PHARMA SCIENCE - Comparison Results

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. STRIDES PHARMA SCIENCE FDC LTD./
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 17.7 8.1 217.8% View Chart
P/BV x 2.7 1.0 274.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 FDC LTD.   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    FDC LTD.
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
FDC LTD./
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3191,147 27.8%   
Low Rs164642 25.5%   
Sales per share (Unadj.) Rs61.6317.2 19.4%  
Earnings per share (Unadj.) Rs9.97.8 126.8%  
Cash flow per share (Unadj.) Rs12.025.1 47.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs73.2274.3 26.7%  
Shares outstanding (eoy) m174.4089.50 194.9%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x3.92.8 138.9%   
Avg P/E ratio x24.3114.0 21.3%  
P/CF ratio (eoy) x20.235.7 56.5%  
Price / Book Value ratio x3.33.3 101.2%  
Dividend payout %025.5 0.0%   
Avg Mkt Cap Rs m42,11880,058 52.6%   
No. of employees `0005.52.5 220.6%   
Total wages/salary Rs m2,1674,341 49.9%   
Avg. sales/employee Rs Th1,943.711,325.8 17.2%   
Avg. wages/employee Rs Th391.71,731.4 22.6%   
Avg. net profit/employee Rs Th313.7280.1 112.0%   
INCOME DATA
Net Sales Rs m10,75128,394 37.9%  
Other income Rs m510941 54.2%   
Total revenues Rs m11,26029,334 38.4%   
Gross profit Rs m2,2673,965 57.2%  
Depreciation Rs m3511,540 22.8%   
Interest Rs m141,962 0.7%   
Profit before tax Rs m2,4111,403 171.8%   
Minority Interest Rs m-50-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m67197 689.8%   
Profit after tax Rs m1,735702 247.1%  
Gross profit margin %21.114.0 151.0%  
Effective tax rate %27.86.9 401.5%   
Net profit margin %16.12.5 652.7%  
BALANCE SHEET DATA
Current assets Rs m7,21324,836 29.0%   
Current liabilities Rs m2,10418,993 11.1%   
Net working cap to sales %47.520.6 230.9%  
Current ratio x3.41.3 262.2%  
Inventory Days Days5471 76.8%  
Debtors Days Days28113 24.4%  
Net fixed assets Rs m6,86534,289 20.0%   
Share capital Rs m175895 19.6%   
"Free" reserves Rs m12,58623,651 53.2%   
Net worth Rs m12,76124,546 52.0%   
Long term debt Rs m615,513 0.0%   
Total assets Rs m15,04165,437 23.0%  
Interest coverage x173.21.7 10,100.1%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x0.70.4 164.7%   
Return on assets %11.64.1 285.6%  
Return on equity %13.62.9 475.3%  
Return on capital %19.06.9 275.0%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88915,697 12.0%   
Fx outflow Rs m0735 0.0%   
Net fx Rs m1,88914,962 12.6%   
CASH FLOW
From Operations Rs m1,4981,871 80.1%  
From Investments Rs m2015,826 3.5%  
From Financial Activity Rs m-1,694-10,157 16.7%  
Net Cashflow Rs m10-2,615 -0.4%  

Share Holding

Indian Promoters % 68.9 27.7 248.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 37.8 12.4%  
FIIs % 7.5 8.6 87.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.9 73.4%  
Shareholders   23,730 56,241 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Remains Rangebound; Bharti Airtel and ONGC Top Losers(12:30 pm)

Stock markets in India are presently trading flat. The BSE Sensex is trading down by 31 points and the NSE Nifty is trading down by 14 points.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Nov 21, 2019 03:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS